Latest current cash for MGX: $25M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Metagenomi (MGX) currently reports a current cash of $25M as of March 2026. That compares with $29M in the prior-year period — down 13.3% year over year. Use the charts on this page to explore Metagenomi's current cash history and peer comparisons.
Metagenomi's current cash decreased from $29M to $25M — a 13.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Metagenomi reported $25M in current cash as of March 2026. That compares with $29M in the prior-year period — down 13.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $25M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Metagenomi, and consider following MGX for alerts when major investors trade the stock.